School of Veterinary Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54124, Greece.
Forest Research Institute, Hellenic Agricultural Organization "DEMETER", Vasilika, 57006, Greece.
Vet Parasitol Reg Stud Reports. 2020 Jan;19:100357. doi: 10.1016/j.vprsr.2019.100357. Epub 2019 Nov 27.
Recently, feline cardio-pulmonary nematodes have attracted high scientific interest, as they are increasingly reported from various areas. Most of these parasites have similar transmission patterns and/or host reservoirs, thus they may affect domestic and wild felids living in sympatry. In the present study, a case of multiple cardio-pulmonary parasitism in co-infection with other parasites in a European wildcat is presented. The animal, found exhausted, was hospitalised for recovery and parasitological, haematological, clinical and imaging examinations were performed. The parasitological examinations revealed 4 cardio-pulmonary nematodes, i.e. Aelurostrongylus abstrusus, Troglostrongylus brevior, Eucoleus aerophilus, Angiostrongylus chabaudi, 3 intestinal parasites, i.e. Toxocara cati, ancylostomatids, Cystoisospora felis, 2 haemoparasites, i.e. Hepatozoon felis and elements morphologically compatible with small Babesia/Cytauxzoon spp., and Ixodes ricinus and Haemaphysalis erinacei ticks. Treatment with a spot-on formulation containing imidacloprid 10% and moxidectin 1% (Advocate® spot-on solution for cats, Bayer) was decided and follow-up faecal examinations were performed until the release of the animal. By the end of the hospitalisation, all metazoan endoparasites were no longer detectable in faecal examinations, with the exception of a low number of A. abstrusus larvae. Thus, the animal was released after a second treatment with the same product. This is the first description of an apparently successful treatment of multiple cardio-respiratory parasitosis in a naturally infected wildcat showing compatible clinical signs. The evidence that Advocate® may be effective against A. chabaudi could be useful for treating infected, hospitalised, wildcats and it is promising in the case A. chabaudi infection will spread to domestic cats in a near future.
最近，猫心肺线虫引起了科学界的高度关注，因为它们在不同地区的报道越来越多。这些寄生虫大多数具有相似的传播模式和/或宿主储集器，因此它们可能会影响共生的家养和野生猫科动物。在本研究中，报告了一只欧洲野生猫同时感染多种心肺寄生虫和其他寄生虫的病例。这只疲惫不堪的动物被送医接受恢复治疗，并进行了寄生虫学、血液学、临床和影像学检查。寄生虫学检查发现了 4 种心肺线虫，即 Aelurostrongylus abstrusus、Troglostrongylus brevior、Eucoleus aerophilus、Angiostrongylus chabaudi，3 种肠道寄生虫，即 Toxocara cati、类圆线虫、Cystoisospora felis，2 种血液寄生虫，即 Hepatozoon felis 和形态上与小 Babesia/Cytauxzoon spp. 相符的元素，以及 Ixodes ricinus 和 Haemaphysalis erinacei 蜱虫。决定使用含有 10%吡虫啉和 1%莫昔克丁的滴剂（Advocate®猫用滴剂，拜耳）进行治疗，并进行后续粪便检查，直到释放动物。在住院治疗结束时，除了少量 A. abstrusus 幼虫外，粪便检查中不再检测到所有后生动物内寄生虫。因此，在第二次使用相同产品治疗后，该动物被释放。这是首例自然感染的野生猫科动物出现多种心肺寄生虫病并显示出相容的临床症状后，成功治疗的描述。Advocate® 可能对 A. chabaudi 有效的证据对治疗受感染的住院野生猫科动物非常有用，如果 A. chabaudi 感染在不久的将来传播到家猫，这将是有希望的。
